Inflammatory Diseases of the Eye

Top drugs studied for this disease

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

FDA approval · 2009-03-20
FDA Approved: DIFLUPREDNATE OPHTHALMIC — Supplemental Application (Sandoz Inc)
FDA approved Sandoz Inc's supplemental application for difluprednate ophthalmic, approving a generic corticosteroid ophthalmic solution for …